Search for: "STATE IN THE INTEREST OF B. J. and J. J." Results 41 - 60 of 4,631
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Apr 2024, 11:33 am by admin
A few months after the Oregon hearings, Judge Weinstein, in the fall of 1996, along with other federal and state judges, held a “Daubert” hearing on the admissibility of expert witness opinion testimony in breast implant cases, pending in New York state and federal courts. [read post]
19 Apr 2024, 9:27 am by CFM Admin
April 19, 2024 Clients, Friends, and Associates: As we end the first quarter and enter the spring season, we would like to highlight some of the recent industry updates and occurrences we found to be both interesting and impactful. [read post]
In considering the criteria, Jackman J noted the Court must take into account the ‘transparency’ of the term, per s 12BG(2)(b), in addition to the contract as a whole, per s 12BG(2)(c), in interpreting unfairness. [read post]
17 Apr 2024, 8:59 am by Eugene Volokh
In Section Five of the order, Defendant provided the following reasoning in support of keeping bars closed: [B]y their very nature, [bars] present greater risks of the spread of COVID-19. [read post]
17 Apr 2024, 7:05 am by Norman L. Eisen
Keith Davidson—Davidson, Clifford’s lawyer, is “Lawyer B” in the statement of facts. [read post]
16 Apr 2024, 6:49 am by Samuel Bray
It's interesting that the question was about an injunction against a state law. [read post]
15 Apr 2024, 9:01 pm by renholding
Reflecting the importance of master account access and its implications for the dual banking system, several third parties, including former Senator Toomey, weighed in on the Custodia case, either as expert witnesses for one of the parties or as interested persons. [read post]
13 Apr 2024, 3:33 pm by admin
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]